Regarding its commitment to tumor metabolic rewiring, in breast cancer, elevated KLF4 expression has been detected and contributes to activating phosphofructokinase (PFKP), a key enzyme involved in the glycolysis pathway [99]. Here, KLF4 is linked to breast cancer.